PharmD Signal

Deep dives, evidence grades, and clinical tools, all in one place.

eConsult Tele-Stewardship Cut Carbapenem Use Without Hospital ID Specialists

carbapenemsantimicrobial stewardshipeConsulttele-stewardshipExpertTWINinfectious diseasesBayesian structural time-seriesdays of therapyantimicrobial resistancepharmacist-led interventionretrospective observational studyClinical Pharmacy Practice Clinical Practice

Background Information

eConsult tele-stewardship cuts carbapenem use, but challenges remain.

Hospitals lacking infectious disease specialists need scalable antimicrobial stewardship programs to manage drug resistance and appropriate antibiotic use. The eConsult-based program reduced carbapenem use and some resistance patterns, but resistance to third-generation cephalosporins increased. This study provides a model for implementing antimicrobial stewardship in resource-limited settings, though clinical outcomes remained unchanged. eConsult-based antimicrobial stewardship can reduce certain drug resistances without affecting mortality or length of stay.

📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.

Authors: Itoh N, Mizuno T, Wachino C, Kuriki S, Nagamizu M, Akazawa-Kai N, Okumura N, Furuya K, Yu K, Kawabata T

Citation: Itoh N, Mizuno T, Wachino C, et al. Impact of an eConsult-based antimicrobial stewardship program using the ExpertTWIN system: a Bayesian structural time-series analysis. Antimicrobial stewardship & healthcare epidemiology : ASHE. 2026;6(1):e255. doi:10.1017/ash.2026.10851

Article Links: PubMed · Journal / DOI · Free Full Text (PMC)

🎓
Reviewed by a licensed pharmacist
Every analysis is reviewed and approved by a licensed pharmacist before publication, ensuring clinical accuracy and relevance.
Accurate and up-to-date information is our highest priority.
If you spot an error, please suggest a correction. If there is a topic you want covered, tell us and we will look at it.
Thanks for the feedback!
🔒
Deep Analysis: Subscribers Only
Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.
Executive Summary
Study Design
Patient Population
Primary Outcomes
Secondary Outcomes & Safety Profile
Pharmacist Implications
Clinical Pearls
Limitations
Controversies & Evidence Gaps
Cost & Logistics
Founding member rate
$8/month. Cancel anytime.

One subscription unlocks this analysis and every other one we publish, plus Practice Signals, PDF reports, and GRADE evidence grades.

Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.
Or $79/year. Founding members keep this rate for as long as they stay subscribed. Cancel anytime from your Account page.